/
/
En omfattende prosedyre for å evaluere<em> I Vivo</em> Utførelse av kreft Nanomedicines
È necessario avere un abbonamento a JoVE per visualizzare questo. Accedi o inizia la tua prova gratuita.
Capitoli
- 00:05Titolo
- 00:56Synthesis of Dual-labeled Liposomal Nanoparticles
- 03:22In Vivo PET-CT Imaging and Ex Vivo Biodistribution Measurements
- 06:19Results: Biodistribution of Fluorescent- and Radiolabeled Nanoparticles in Tumor-bearing Mice
- 07:14Conclusion
The poor understanding of the in vivo performance of nanomedicines stymies their clinical translation. Procedures to evaluate the in vivo behavior of cancer nanomedicines at systemic, tissue, single-cell, and subcellular levels in tumor-bearing immunocompetent mice are described here. This approach may help researchers to identify promising cancer nanomedicines for clinical translation.
